BioLife Solutions Inc BLFS
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Are BLFS, FTHM, AUUD, VRME Obtaining Fair Deals for their Shareholders?
-
BioLife Solutions Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of BioLife Solutions, Inc. - BLFS
-
BLFS Stock Alert: Halper Sadeh LLC is Investigating Whether BioLife Solutions, Inc. is Obtaining a Fair Price for its Shareholders
-
BioLife Solutions Reports Second Quarter 2026 Financial Results
-
$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger—LXP, BLFS, PSNL, and FNWD
-
Are NG, BLFS, NRIM Obtaining Fair Deals for their Shareholders?
-
BioLife Solutions Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of BioLife Solutions, Inc. - BLFS
-
Are UTZ, BLFS, FNWD Obtaining Fair Deals for their Shareholders?
Trading Information
- Previous Close Price
- $38.85
- Day Range
- $36.70–38.90
- 52-Week Range
- $17.86–39.76
- Bid/Ask
- $34.51 / $38.47
- Shares Outstanding
- 48.92M
- Market Cap
- $1.80B
- Volume/Avg
- 919,393 / 1M
Key Statistics
- Price/Earnings (Normalized)
- 36.62
- Price/Sales
- 17.72
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Small Growth
- Total Number of Employees
- 155
- Website
- https://www.biolifesolutions.com
Valuation
|
Metric
|
BLFS
|
|---|---|
Price/Earnings (Normalized) | 36.62 |
Price/Book Value | 4.28 |
Price/Sales | 17.72 |
Price/Cash Flow | 57.39 |
Price/Earnings
BLFS
Financial Strength
|
Metric
|
BLFS
|
|---|---|
Quick Ratio | 6.67 |
Current Ratio | 9.69 |
Interest Coverage | — |
Quick Ratio
BLFS
Profitability
|
Metric
|
BLFS
|
|---|---|
Return on Assets (Normalized) | 2.52% |
Return on Equity (Normalized) | 2.75% |
Return on Invested Capital (Normalized) | 1.94% |
Return on Assets
BLFS
Medical Instruments & Supplies Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc
ISRG
| LOCK|&kjS&<?% | LOCK|^r | $142B | |||
| Becton Dickinson & Co
BDX
| LOCK|#$ | LOCK|HT?wy | $49B | |||
| ResMed Inc
RMD
| LOCK|BqGc%$K | LOCK|YF?# | $32B | |||
| Medline Inc Ordinary Shares - Class A
MDLN
| LOCK|dW^>Zl? | LOCK|ydg& | $31B | |||
| Alcon Inc
ALC
| LOCK|@JyKwys | LOCK|%Kc@ | $31B | |||
| West Pharmaceutical Services Inc
WST
| LOCK|#?@Ml&%! | LOCK|v< | $26B | |||
| Solventum Corp
SOLV
| LOCK|>!!x&%V | LOCK|Bb! | $15B | |||
| Baxter International Inc
BAX
| LOCK|x& | LOCK|tpKT% | $12B | |||
| The Cooper Companies Inc
COO
| LOCK|#Dj@H^ | LOCK|?V?z | $11B | |||
| Align Technology Inc
ALGN
| LOCK|?m&>@D | LOCK|w>%w< | $10B |
United States